Why is GKB Ophthalmics falling/rising?

As of 01-Aug, GKB Ophthalmics Ltd is experiencing a price increase, currently at Rs 82.10, reflecting a rise of 9.0 or 12.31%. The stock has outperformed its sector today by 11.61%, opening with a gain of 5.34% and reaching an intraday high of Rs 84.9, which is a 16.14% increase. Despite this positive movement, the stock has shown significant volatility, with an intraday volatility of 5.86%. However, the company's long-term fundamentals remain weak, as indicated by operating losses and a poor EBIT to Interest ratio of -0.47. The stock has consistently underperformed against benchmarks over the past year, with a return of -28.61% and a notable decline in profitability, as evidenced by a PAT of Rs -3.55 crore, which has fallen by 222% compared to the previous four-quarter average.
In the broader market context, GKB Ophthalmics has shown a positive short-term return of 10.92% over the past week, while the benchmark Sensex has declined by 1.06% during the same period. This indicates that the stock is gaining traction relative to the market, despite its overall underperformance in the longer term. The company's liquidity appears adequate for trading, but the significant drop in delivery volume by 99.91% suggests a decrease in investor participation, which could be a concern for sustained price increases. Overall, while the stock is currently rising, its long-term outlook remains precarious due to ongoing operational challenges and historical underperformance.